Model
Edge
Alnylam Pharmaceuticals, Inc.
0001708764
Filing type
4
Filing date
Apr 9, 2023
Updated
Apr 10, 2023 ยท 10:29 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership